Pasquale Niscola

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients

Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni et al. · Blood · 2014 · 372 citations · Full text

Life Sciences, Hematology, Immunology +12

Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia

Maria Ilaria Del Principe, Giovanni Del Poeta, Francesco Buccisano et al. · Blood · 2006 · 187 citations

Medicine, Hematology, Immunology +13

Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi.

Massimo Federico, Umberto Vitolo, Pier Luigi Zinzani et al. · PubMed · 2000 · 184 citations

Medicine, Hematology, Oncology +13

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini et al. · The Lancet Haematology · 2017 · 162 citations · Full text

Medicine, Hematology, Pharmacotherapy +8

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Maria Teresa Voso, Susanna Fenu, Roberto Latagliata et al. · Journal of Clinical Oncology · 2013 · 137 citations · Full text

Medicine, Hematology, Internal Medicine +17